Advertisement
Table 2 Characteristics of the sample (n = 250)
| Variable | Categories | Value |
|---|---|---|
| Age | Mean= 54 (sd = 13) | |
| Gender | Male | 142 (56.8%) |
| Living alone | No | 194 (77.6%) |
| Employed | Yes | 130 (52.0%) |
| Education | until age 11/12 years | 33 (13.2%) |
| until age 12/13–14/15 years | 118 (47.2%) | |
| until age 15/16–18/19 years | 26 (10.4%) | |
| advanced (college) | 73 (29.2%) | |
| Nationality | Swiss | 209 (83.6%) |
| Immunosuppression | Cyclosporine & mycophenolate mofetil | 71 (28.4%) |
| Cyclosporine | 38 (15.2%) | |
| Cyclosporine & azathioprine | 37 (14.8%) | |
| Azathioprine & prednisone | 18 (7.2%) | |
| Azathioprine & tacrolimus | 14 (5.6%) | |
| Other combinations | 72 (28.8%) | |
| Monitored immunosuppressives | Mycophenolate mofetil | 103 (41.2%) |
| Cyclosporine | 89 (35.6%) | |
| Azathioprine/prednisone | 19 (7.6%) | |
| Tacrolimus | 37 (14.8%) | |
| Sirolimus | 2 (0.8%) | |
| Self-reported EM influence on typical adherence | No influence | 188 (76.1%) |
| Positive influence | 53 (21.5%) | |
| Negative influence | 6 (2.4%) |
